Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

727
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
727
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

1.1K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.1K
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

806
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
806

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Literature-based case analysis of serious adverse drug events associated with edoxaban.

European journal of clinical pharmacology·2025
Same author

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase.

European journal of clinical pharmacology·2022
Same author

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase.

Drug safety·2022
Same author

Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria.

Drugs - real world outcomes·2022
Same author

The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.

Drug safety·2021
Same author

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase.

The European respiratory journal·2021

Related Experiment Video

Updated: Jul 4, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.2K

Dabigatran-related serious medication errors: an analysis using data from VigiBase.

Qingxia Zhang1, Qian Ding2, Qun-Ying Yue3

  • 1Department of Pharmacy, National Clinical Research Center for Geriatric Disease, Xuanwu Hospital Capital Medical University, Beijing, China. WL7322681@sina.com.

European Journal of Clinical Pharmacology
|January 28, 2024
PubMed
Summary
This summary is machine-generated.

Serious medication errors (MEs) with dabigatran often occur during prescription and administration, leading to adverse events like bleeding and ischemia. Careful dosing, patient compliance, and proper storage are crucial to prevent harm.

Keywords:
DabigatranDosage errorDrug interactionMedication errorSeriousVigiBase

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Related Experiment Videos

Last Updated: Jul 4, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.2K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Clinical Pharmacy

Background:

  • Dabigatran is an anticoagulant used to prevent stroke and blood clots.
  • Medication errors (MEs) can lead to serious adverse events.
  • Analyzing MEs is crucial for improving patient safety.

Purpose of the Study:

  • To analyze serious medication errors (MEs) related to dabigatran.
  • To identify factors contributing to these MEs.
  • To provide insights for preventing adverse events.

Main Methods:

  • Serious MEs involving dabigatran were extracted from WHO's VigiBase.
  • Analysis included well-documented reports with a vigiGrade score ≥ 0.80.
  • The PCNE Classification for drug-related problems (DRP) was used.

Main Results:

  • 113 well-documented serious MEs were analyzed, with 61% leading to hospitalization and 11% to death.
  • Prescription errors (77 cases) included drug selection (contraindications, interactions) and dosing issues.
  • Administration errors (35 cases) involved medical staff and patient-related issues, with bleeding and ischemia as primary adverse events.

Conclusions:

  • Serious MEs with dabigatran predominantly occur during prescription and administration.
  • Ensuring correct dose selection for the right patient is vital.
  • Patient adherence and proper drug storage are critical during administration to minimize harm.